Current Issue

View Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences

Featured Articles

Scheduling and Optimization of Biomanufacturing Activities in Multi-product Facilities with Disposable Technologies

Gloria Gadea-Lopez, Ph.D. is Director of Production and Business Systems at the Shire Lexington, John Maguireis the Associate Director of Manufacturing Systems at Shire’s Lexington and Megan Rabideau is a Manufacturing Systems Engineer at Shire’s Lexington

Process Analytical Technology For Upstream Bioprocessing

Erica Fratz-Berilla and Cyrus Agarabi, FDA CDER

Characterization and Engineering Performance of the Allegro™ STR 500 Single-Use Stirred Tank Bioreactor

Benefits of Mixed-Mode Cation Exchange Chromatography: CMM HyperCel™ Sorbent Used for Monoclonal Antibody and Other Recombinant Protein Purification

View All Featured Articles

Headline News

AbbVie’s dual targeting ABBV-466 beats single drug treatment on endoscopic remission in Phase 2a Crohn’s disease study

Sanofi signs on as first company to sponsor white jersey at both Tour de France and Tour de France Femmes

GSK’s Jemperli wins FDA approval as first immunotherapy for MSI-H/dMMR locally advanced rectal cancer

Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Accelerating the development of regenerative therapies: Large scale expansion of human mesenchymal stem cells

Presented by Jon Rowley, Ph.D. & Mark Szczypka, Ph.D.
28th March 2017

Subvisible Particle Identification & Characterisation by Multi-Technique Methods

Presented by Dr. Jonas Hoeg Thygesen, Novo Nordisk Pharmatech. Followed by Colin Merrifield, ProteinSimple
23rd February 2017

The Disposable Facility and Single-Use Technology – a Solution or a Revolution? Sponsored by PALL

Presented by Dr Joachim Walter, Consultant at Walter Biotech Consultancy and Jerold Martin Sr. Vice President, Global Scientific Affairs for Pall Life Sciences
18th September 2013

View All Past Webinars

Featured Companies

View All Companies

Featured Video

At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.

There’s no kit for the perfect biotech process. Until now.

View All Videos